These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An overview of the analysis and interpretation of bioavailability studies in man. Wagner JG Pharmacology; 1972; 8(1):102-17. PubMed ID: 4644642 [No Abstract] [Full Text] [Related]
6. Proceedings: Mechanisms of drug absorption and of drug solution. Jollow DJ Rev Can Biol; 1973; 32():Suppl:7-19. PubMed ID: 4777606 [No Abstract] [Full Text] [Related]
7. Tableting research and technology. Cooper J; Rees JE J Pharm Sci; 1972 Oct; 61(10):1511-55. PubMed ID: 4561201 [No Abstract] [Full Text] [Related]
8. Effect of route of administration on drug disposition. Riegelman S; Rowland M J Pharmacokinet Biopharm; 1973 Oct; 1(5):419-34. PubMed ID: 4787618 [No Abstract] [Full Text] [Related]
9. Mechanisms of drug absorption and of drug solution. Jollow DJ; Brodie BB Pharmacology; 1972; 8(1):21-32. PubMed ID: 4644653 [No Abstract] [Full Text] [Related]
10. [A pharmacokinetic function for galenics]. Dost FH Arzneimittelforschung; 1971 May; 21(5):712-7. PubMed ID: 5109699 [No Abstract] [Full Text] [Related]
11. Regional intestinal drug permeation: biopharmaceutics and drug development. Lennernäs H Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845 [TBL] [Abstract][Full Text] [Related]
12. The developability classification system: application of biopharmaceutics concepts to formulation development. Butler JM; Dressman JB J Pharm Sci; 2010 Dec; 99(12):4940-54. PubMed ID: 20821390 [TBL] [Abstract][Full Text] [Related]
13. Is the full potential of the biopharmaceutics classification system reached? Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971 [TBL] [Abstract][Full Text] [Related]
14. Keeping bioavailability in perspective. Schumacher GE Am J Hosp Pharm; 1973 Feb; 30(2):150-4. PubMed ID: 4690469 [No Abstract] [Full Text] [Related]
15. Calculating absorption rate constants for drugs with incomplete availability. Leeson LJ; Weintraub H J Pharm Sci; 1973 Dec; 62(12):1936-41. PubMed ID: 4762161 [No Abstract] [Full Text] [Related]
16. Bioavailability of drugs (first of two parts). Koch-Weser J N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408 [No Abstract] [Full Text] [Related]